Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Macrogenics (MGNX)

Macrogenics (MGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 952,178
  • Shares Outstanding, K 62,561
  • Annual Sales, $ 58,750 K
  • Annual Income, $ -9,060 K
  • 60-Month Beta 2.09
  • Price/Sales 16.56
  • Price/Cash Flow N/A
  • Price/Book 6.01
Trade MGNX with:

Options Overview Details

View History
  • Implied Volatility 176.11% ( -17.45%)
  • Historical Volatility 94.23%
  • IV Percentile 97%
  • IV Rank 70.21%
  • IV High 236.09% on 06/23/23
  • IV Low 34.70% on 08/17/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 152
  • Volume Avg (30-Day) 898
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 22,316
  • Open Int (30-Day) 17,375

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.67
  • Number of Estimates 4
  • High Estimate -0.62
  • Low Estimate -0.75
  • Prior Year -0.61
  • Growth Rate Est. (year over year) -9.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.13 +11.46%
on 04/25/24
19.54 -19.40%
on 04/09/24
+2.08 (+15.22%)
since 04/03/24
3-Month
12.82 +22.85%
on 04/03/24
21.88 -28.02%
on 03/06/24
+0.31 (+1.97%)
since 02/02/24
52-Week
4.29 +267.13%
on 10/03/23
21.88 -28.02%
on 03/06/24
+8.86 (+128.59%)
since 05/03/23

Most Recent Stories

More News
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050

/CNW/ -- USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of...

BIOV.CN : 0.0800 (unch)
BVAXF : 0.0624 (-0.16%)
MRNA : 124.89 (-0.56%)
BOLD : 8.89 (-1.82%)
IBRX : 9.60 (+7.02%)
MGNX : 15.64 (+2.76%)
Promising Outlook as Biotech Sector Advances Cancer Treatments Amidst Rising Diagnoses

USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of cancer. A new report from the American Cancer Society...

BRX : 22.26 (-0.71%)
BIOV.CN : 0.0800 (unch)
BVAXF : 0.0624 (-0.16%)
MRNA : 124.89 (-0.56%)
BOLD : 8.89 (-1.82%)
IBRX : 9.60 (+7.02%)
MGNX : 15.64 (+2.76%)
Hawkish Fed Comments Knock Stocks Lower

The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -1.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.55%. Stocks on...

$SPX : 5,114.55 (+0.99%)
SPY : 508.85 (+0.76%)
$DOWI : 38,633.37 (+1.07%)
DIA : 385.47 (+0.85%)
$IUXX : 17,834.35 (+1.67%)
QQQ : 433.08 (+1.45%)
ZNM24 : 108-215 (+0.29%)
LW : 84.71 (+0.27%)
PARA : 14.39 (+3.82%)
ABBV : 162.24 (+0.89%)
NVDA : 874.34 (+1.88%)
MU : 113.74 (+1.26%)
Stocks Slide in Today's Afternoon Trading Session

The S&P 500 Index ($SPX ) (SPY ) is down -0.78%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.81%. Stocks are lower this afternoon,...

$SPX : 5,114.55 (+0.99%)
SPY : 508.85 (+0.76%)
$DOWI : 38,633.37 (+1.07%)
DIA : 385.47 (+0.85%)
$IUXX : 17,834.35 (+1.67%)
QQQ : 433.08 (+1.45%)
ZNM24 : 108-215 (+0.29%)
CAG : 30.68 (-0.55%)
GFS : 48.92 (+1.33%)
AVGO : 1,253.89 (+1.24%)
MCHP : 91.08 (+1.81%)
ON : 70.89 (+1.26%)
Stocks Push Higher on Strength in Chip Stocks and Lower Bond Yields

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.72%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.92%. Stocks are higher today...

$SPX : 5,114.55 (+0.99%)
SPY : 508.85 (+0.76%)
$DOWI : 38,633.37 (+1.07%)
DIA : 385.47 (+0.85%)
$IUXX : 17,834.35 (+1.67%)
QQQ : 433.08 (+1.45%)
ZNM24 : 108-215 (+0.29%)
CAG : 30.68 (-0.55%)
MRVL : 68.06 (+2.08%)
WDC : 70.69 (+1.39%)
NVDA : 874.34 (+1.88%)
MU : 113.74 (+1.26%)
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript

MGNX earnings call for the period ending December 31, 2023.

MGNX : 15.64 (+2.76%)
MacroGenics (MGNX) Q3 2023 Earnings Call Transcript

MGNX earnings call for the period ending September 30, 2023.

MGNX : 15.64 (+2.76%)
MacroGenics: Q3 Earnings Snapshot

MacroGenics: Q3 Earnings Snapshot

MGNX : 15.64 (+2.76%)
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race

Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant...

DTC.CN : 1.5000 (-7.41%)
MGNX : 15.64 (+2.76%)
IOVA : 13.57 (+5.36%)
MRTX : 58.70 (-0.17%)
MRSN : 3.56 (+5.95%)
DTCFF : 0.8561 (-2.49%)
LLY : 734.52 (-2.83%)
PFE : 27.64 (-0.22%)
3 Under-the-Radar Biotech Stocks to Buy in 2023

All three biotech companies focus on oncology therapies.

DCPH : 25.40 (+0.08%)
MRTX : 58.70 (-0.17%)
MGNX : 15.64 (+2.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics...

See More

Key Turning Points

3rd Resistance Point 16.58
2nd Resistance Point 16.28
1st Resistance Point 15.75
Last Price 15.64
1st Support Level 14.93
2nd Support Level 14.63
3rd Support Level 14.10

See More

52-Week High 21.88
Last Price 15.64
Fibonacci 61.8% 15.16
Fibonacci 50% 13.08
Fibonacci 38.2% 11.01
52-Week Low 4.29

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar